Pan Cancer T celebrates 1-year anniversary!

TCR T cells towards solid tumors: perspective on pitfalls and opportunities
1 september 2021
Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital
28 oktober 2021

Pan Cancer T celebrates 1-year anniversary!

Pan Cancer T B-day_2021 (2)

Related posts

16 januari 2025

Pan Cancer T BV extends partnership with NecstGen BV by initiating retroviral vector development

Read more
11 juli 2024

Pan Cancer T secures eur 4.25 Million in Seed Extension Round to advance next-generation T cell therapies

Read more
9 juli 2024

Erasmus MC together with Pan Cancer T receive KWF-PPS grant to develop next-generation T cell therapy

Read more